Vítězslav Bryja (Lukáš Smolej)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Cancer medicine

British journal of haematology

Cancers

European journal of clinical investigation

Fakultní Nemocnice Hradec Králové

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fakultní Nemocnice Hradec Králové

Czechia

Deputy Head for Science :: 4th Department of Medicine - Hematology

Univerzita Karlova v Praze Nov 28 2019

Czechia

Professor :: Internal Medicine

Publications

Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy. Cancer medicine 13 (15) (2024)
Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy. Cancer medicine 13 (15) (2024)
Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy. Cancer medicine 13 (15) (2024)
Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia. Cancer medicine (2022)
Vítězslav Bryja, Yvona Brychtová, Eduard Cmunt, Michael Doubek, Martin Špaček, David Belada, Martin Šimkovič, Lukáš Stejskal, Irena Zygulová, Renata Urbanová, Martin Brejcha, Jana Zuchnická, Heidi Móciková, Tomáš Kozák, null null
Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group. British journal of haematology 193 (4) (2021)
Vítězslav Bryja, Pavel Vodárek, Dominika Écsiová, Martin Simkovic
Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking? Cancers 13 (13) (2021)
Vítězslav Bryja
On the road to optimized BTK inhibition in CLL. Blood 137 (24) (2021)
Vítězslav Bryja, Peter Turcsanyi, Zuzana Kubová, Jana Zuchnická, Jana Mihályová, Martin Šimkovič, Pavel Vodárek, Mária Krčméryová, Heidi Móciková, Martin Brejcha, Martin Špaček, null null
External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score. British journal of haematology 193 (1) (2020)
Vítězslav Bryja
Skipping a step: what happened to the design of randomized clinical trials in chronic lymphocytic leukaemia? British journal of haematology 193 (4) (2020)
Martin Simkovic, Pavel Vodárek, Monika Motyčková, Dominika Écsiová, Petra Rozsívalová, Heidi Móciková, Pavla Štěpánková, Alice Sýkorová, Kateřina Hrochová, Filip Vrbacký, David Belada, Pavel Žák, Vítězslav Bryja
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia. European journal of clinical investigation 51 (4) (2020)
Anna Kotrbová, Karel Štěpka, Martin Maška, Jakub Jozef Pálenik, Ladislav Ilkovics, Dobromila Klemová, Marek Kravec, František Hubatka, Zankruti Dave, Aleš Hampl, Vítězslav Bryja, Pavel Matula, Vendula Pospíchalová
TEM ExosomeAnalyzer: a computer-assisted software tool for quantitative evaluation of extracellular vesicles in transmission electron microscopy images. Journal of extracellular vesicles 8 (1) (2019)

Vítězslav Bryja.css-eqlu8i{font-size:small;padding-left:4px;} (Lukáš Smolej)

Publication Activity (10 Years)

Top Topics

Top Venues

Vítězslav Bryja (Lukáš Smolej)